Eli Lilly testosterone replacement manufacturer MDL
Illinois Court Selects Two Bellwether Cases in Testosterone Replacement Trial
June 30, 2017
The U.S. District Court for the Northern District of Illinois has selected two cases that will represent more than 6000 others in a Multi-District Litigation (MDL) case against testosterone replacement drug manufacturer Eli Lilly. These “bellwether trials” typically set precedents for future rulings in similar cases.
Tracy Garner, plaintiff in one of the bellwether cases, suffered a myocardial infarction; John Debroka, plaintiff in the other bellwether case, suffered deep vein thrombosis. Both plaintiffs – along with the plaintiffs in the other 6000 cases – allege that topical testosterone replacement drugs, such as Eli Lilly’s Axiron, are to blame for their health crises.
Other major drug manufacturers that have released topical testosterone products include AbbVie, Actavis, Auxilium Pharmaceuticals, Endo Pharmaceuticals, Pharmacia, and Pfizer.
The central issue in the cases is whether topical testosterone treatments can cause such serious medical conditions as deep vein thrombosis, heart attacks, pulmonary embolisms, and strokes.
Testosterone therapy drugs, whether topical or oral, are prescribed for a range of symptoms, including decreased muscle mass, depleted energy, and reduction in libido.
The U.S. Food and Drug Administration (FDA) has been investigating topical testosterone drugs since 2014, and in 2015 issued a formal warning about the products.
If you or a loved one has suffered health problems as a result of using topical testosterone replacement drugs – or from any other drug that you believe to be a health risk – contact your doctor.
Then, contact TheLawFirm.com. The consultation is always free, and we will always advocate for your health.
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!